← Browse by Condition
Medical Condition
gastroesophageal junction adenocarcinoma
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for gastroesophageal junction adenocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — gastroesophageal junction adenocarcinoma Clinical Trials
How many clinical trials are currently recruiting for gastroesophageal junction adenocarcinoma?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for gastroesophageal junction adenocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for gastroesophageal junction adenocarcinoma?
gastroesophageal junction adenocarcinoma research spans Phase 1 (4 trials), Phase 2 (6 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a gastroesophageal junction adenocarcinoma clinical trial?
Eligibility criteria for gastroesophageal junction adenocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 6
Phase 3 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07179484
Recruiting
Enrollment
20 pts
Location
China
Sponsor
Beijing GoBroad Hospital
NCT06340711 Phase 2
Recruiting
Enrollment
27 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT06792435 Phase 1, Phase 2
Recruiting
Enrollment
240 pts
Location
China
Sponsor
Evopoint Biosciences Inc.
NCT06221748 Phase 2, Phase 3
Recruiting
Enrollment
90 pts
Location
China
Sponsor
RemeGen Co., Ltd.
NCT07182565 Phase 1, Phase 2
Recruiting
Enrollment
84 pts
Location
China
Sponsor
West China Hospital
NCT04389632 Phase 1
Recruiting
Enrollment
1,006 pts
Location
United States, Franc...
Sponsor
Seagen, a wholly owned subsidi...
NCT06324357 Phase 1, Phase 2
Recruiting
Enrollment
768 pts
Location
United States, Belgi...
Sponsor
Boehringer Ingelheim
NCT07102901 Phase 2
Recruiting
Enrollment
351 pts
Location
China
Sponsor
Jiangsu HengRui Medicine Co., ...
NCT07152405 Phase 3
Recruiting
Enrollment
490 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
Related Conditions
esophageal adenocarcinoma (3) gastric adenocarcinoma (2) pancreatic adenocarcinoma metastatic (1) lung cancer nsclc (1) ovarian cancer (1) colorectal cancer metastatic (1) biliary tract cancer (1) gastric carcinoma (1) gastric cancer (1) hypofractionated radiotherapy (1) carcinoma non small cell lung (1) squamous cell carcinoma of head and neck (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology